These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21674721)

  • 21. Bevacizumab in first-line treatment of metastatic breast cancer: a viewpoint by Xavier Pivot.
    Pivot X
    Drugs; 2007; 67(12):1800-1. PubMed ID: 17683176
    [No Abstract]   [Full Text] [Related]  

  • 22. Bevacizumab and surgery: what is the real risk?
    Cohen R; Stebbing J; Windsor A
    Future Oncol; 2009 Sep; 5(7):915-7. PubMed ID: 19792957
    [No Abstract]   [Full Text] [Related]  

  • 23. Bevacizumab for retinopathy of prematurity.
    Gilbert CE; Zin A; Darlow B
    N Engl J Med; 2011 Jun; 364(24):2359-60; author reply 2361-2. PubMed ID: 21675898
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma.
    Terheyden P; Hofmann MA; Weininger M; Bröcker EB; Becker JC
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):897-901. PubMed ID: 17583821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bevacizumab: one treatment for all the seasons?
    Gelibter AJ; Di Segni S; Zeuli M; Cognetti F
    J Clin Oncol; 2008 Jan; 26(3):511; author reply 511-2. PubMed ID: 18202430
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma.
    von Buelow M; Pape S; Hoerauf H
    Acta Ophthalmol Scand; 2007 Feb; 85(1):114-6. PubMed ID: 17244223
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravitreal bevacizumab for vitreous haemorrhage.
    Jonas JB; Libondi T; von Baltz S; Vossmerbaeumer U
    Acta Ophthalmol; 2008 Aug; 86(5):585-6. PubMed ID: 18081904
    [No Abstract]   [Full Text] [Related]  

  • 28. Bevacizumab: a potential agent for prevention and treatment of hypertrophic scar.
    Diao JS; Xia WS; Guo SZ
    Burns; 2010 Nov; 36(7):1136-7. PubMed ID: 20378254
    [No Abstract]   [Full Text] [Related]  

  • 29. Targeted therapies: bevacizumab--has it reached its final resting place?
    Kerr DJ; Young AM
    Nat Rev Clin Oncol; 2011 Mar; 8(4):195-6. PubMed ID: 21386819
    [No Abstract]   [Full Text] [Related]  

  • 30. [New medications; bevacizumab].
    Cohen AF; van Bronswijk H
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2194-5. PubMed ID: 17061430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bevacizumab for retinopathy of prematurity.
    Lim LS; Mitchell P; Wong TY
    N Engl J Med; 2011 Jun; 364(24):2360; author reply 2361-2. PubMed ID: 21675897
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-VEGF therapy: riding the wave of change.
    Hunyor AP
    Clin Exp Ophthalmol; 2008 Jul; 36(5):401-2. PubMed ID: 18925912
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of diabetic retinopathy with anti-VEGF drugs.
    Waisbourd M; Goldstein M; Loewenstein A
    Acta Ophthalmol; 2011 May; 89(3):203-7. PubMed ID: 21044274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bevacizumab beyond progression: does this make sense?
    Ellis LM; Haller DG
    J Clin Oncol; 2008 Nov; 26(33):5313-5. PubMed ID: 18854567
    [No Abstract]   [Full Text] [Related]  

  • 35. [The safety of perioperative bevacizumab use].
    Mariani P
    J Chir (Paris); 2010 Jan; 147 Suppl 1():S12-7. PubMed ID: 20172200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers in breast cancer.
    McArthur HL; Dickler MN
    Cancer Biol Ther; 2008 Jan; 7(1):21-2. PubMed ID: 18347421
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anti-angiogenetic agents for solid tumors].
    Blay JY
    Rev Med Interne; 2007 Jun; 28 Suppl 1():S7-8. PubMed ID: 17482319
    [No Abstract]   [Full Text] [Related]  

  • 38. Bevacizumab in advanced lung cancer: in search of the right drug for the right patient.
    Burns TF; Juergens RA
    Oncology (Williston Park); 2010 Nov; 24(13):1223-4, 1226. PubMed ID: 21192562
    [No Abstract]   [Full Text] [Related]  

  • 39. Topical bevacizumab therapy for corneal neovascularization.
    DeStafeno JJ; Kim T
    Arch Ophthalmol; 2007 Jun; 125(6):834-6. PubMed ID: 17562998
    [No Abstract]   [Full Text] [Related]  

  • 40. Gastrointestinal perforation due to bevacizumab in colorectal cancer.
    Saif MW; Elfiky A; Salem RR
    Ann Surg Oncol; 2007 Jun; 14(6):1860-9. PubMed ID: 17356952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.